Insulin resistance and gray matter volume in neurodegenerative disease

J. K. Morris, E. D. Vidoni, R. D. Perea, R. Rada, David K Johnson, K. Lyons, R. Pahwa, J. M. Burns, R. A. Honea

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The goal of this study was to compare insulin resistance in aging and aging-related neurodegenerative diseases, and to determine the relationship between insulin resistance and gray matter volume (GMV) in each cohort using an unbiased, voxel-based approach. Insulin resistance was estimated in apparently healthy elderly control (HC, n= 21) and neurodegenerative disease (Alzheimer's disease (AD), n= 20; Parkinson's disease (PD), n= 22) groups using Homeostasis Model Assessment of Insulin Resistance 2 (HOMA2) and intravenous glucose tolerance test (IVGTT). HOMA2 and GMV were assessed within groups through General Linear Model multiple regression. We found that HOMA2 was increased in both AD and PD compared to the HC group (HC vs. AD, p= 0.002, HC vs. PD, p= 0.003), although only AD subjects exhibited increased fasting glucose (p= 0.005). Furthermore, our voxel-based morphometry analysis revealed that HOMA2 was related to GMV in all cohorts in a region-specific manner (p<. 0.001, uncorrected). Significant relationships were observed in the medial prefrontal cortex (HC), medial temporal regions (AD), and parietal regions (PD). Finally, the directionality of the relationship between HOMA2 and GMV was disease-specific. Both HC and AD subjects exhibited negative relationships between HOMA2 and brain volume (increased HOMA2 associated with decreased brain volume), while a positive relationship was observed in PD. This cross-sectional study suggests that insulin resistance is increased in neurodegenerative disease, and that individuals with AD appear to have more severe metabolic dysfunction than individuals with PD or PD dementia.

Original languageEnglish (US)
Pages (from-to)139-147
Number of pages9
JournalNeuroscience
Volume270
DOIs
StatePublished - Jun 13 2014
Externally publishedYes

Fingerprint

Neurodegenerative Diseases
Insulin Resistance
Parkinson Disease
Alzheimer Disease
Homeostasis
Gray Matter
Parietal Lobe
Brain
Temporal Lobe
Glucose Tolerance Test
Prefrontal Cortex
Dementia
Linear Models
Fasting
Cross-Sectional Studies
Glucose

Keywords

  • Alzheimer's disease
  • Dementia
  • Glucose tolerance
  • Insulin resistance
  • Metabolism
  • Parkinson's disease

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Morris, J. K., Vidoni, E. D., Perea, R. D., Rada, R., Johnson, D. K., Lyons, K., ... Honea, R. A. (2014). Insulin resistance and gray matter volume in neurodegenerative disease. Neuroscience, 270, 139-147. https://doi.org/10.1016/j.neuroscience.2014.04.006

Insulin resistance and gray matter volume in neurodegenerative disease. / Morris, J. K.; Vidoni, E. D.; Perea, R. D.; Rada, R.; Johnson, David K; Lyons, K.; Pahwa, R.; Burns, J. M.; Honea, R. A.

In: Neuroscience, Vol. 270, 13.06.2014, p. 139-147.

Research output: Contribution to journalArticle

Morris, JK, Vidoni, ED, Perea, RD, Rada, R, Johnson, DK, Lyons, K, Pahwa, R, Burns, JM & Honea, RA 2014, 'Insulin resistance and gray matter volume in neurodegenerative disease', Neuroscience, vol. 270, pp. 139-147. https://doi.org/10.1016/j.neuroscience.2014.04.006
Morris, J. K. ; Vidoni, E. D. ; Perea, R. D. ; Rada, R. ; Johnson, David K ; Lyons, K. ; Pahwa, R. ; Burns, J. M. ; Honea, R. A. / Insulin resistance and gray matter volume in neurodegenerative disease. In: Neuroscience. 2014 ; Vol. 270. pp. 139-147.
@article{a5716be7bf3f4e7e8aa30a6bdd72f963,
title = "Insulin resistance and gray matter volume in neurodegenerative disease",
abstract = "The goal of this study was to compare insulin resistance in aging and aging-related neurodegenerative diseases, and to determine the relationship between insulin resistance and gray matter volume (GMV) in each cohort using an unbiased, voxel-based approach. Insulin resistance was estimated in apparently healthy elderly control (HC, n= 21) and neurodegenerative disease (Alzheimer's disease (AD), n= 20; Parkinson's disease (PD), n= 22) groups using Homeostasis Model Assessment of Insulin Resistance 2 (HOMA2) and intravenous glucose tolerance test (IVGTT). HOMA2 and GMV were assessed within groups through General Linear Model multiple regression. We found that HOMA2 was increased in both AD and PD compared to the HC group (HC vs. AD, p= 0.002, HC vs. PD, p= 0.003), although only AD subjects exhibited increased fasting glucose (p= 0.005). Furthermore, our voxel-based morphometry analysis revealed that HOMA2 was related to GMV in all cohorts in a region-specific manner (p<. 0.001, uncorrected). Significant relationships were observed in the medial prefrontal cortex (HC), medial temporal regions (AD), and parietal regions (PD). Finally, the directionality of the relationship between HOMA2 and GMV was disease-specific. Both HC and AD subjects exhibited negative relationships between HOMA2 and brain volume (increased HOMA2 associated with decreased brain volume), while a positive relationship was observed in PD. This cross-sectional study suggests that insulin resistance is increased in neurodegenerative disease, and that individuals with AD appear to have more severe metabolic dysfunction than individuals with PD or PD dementia.",
keywords = "Alzheimer's disease, Dementia, Glucose tolerance, Insulin resistance, Metabolism, Parkinson's disease",
author = "Morris, {J. K.} and Vidoni, {E. D.} and Perea, {R. D.} and R. Rada and Johnson, {David K} and K. Lyons and R. Pahwa and Burns, {J. M.} and Honea, {R. A.}",
year = "2014",
month = "6",
day = "13",
doi = "10.1016/j.neuroscience.2014.04.006",
language = "English (US)",
volume = "270",
pages = "139--147",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Insulin resistance and gray matter volume in neurodegenerative disease

AU - Morris, J. K.

AU - Vidoni, E. D.

AU - Perea, R. D.

AU - Rada, R.

AU - Johnson, David K

AU - Lyons, K.

AU - Pahwa, R.

AU - Burns, J. M.

AU - Honea, R. A.

PY - 2014/6/13

Y1 - 2014/6/13

N2 - The goal of this study was to compare insulin resistance in aging and aging-related neurodegenerative diseases, and to determine the relationship between insulin resistance and gray matter volume (GMV) in each cohort using an unbiased, voxel-based approach. Insulin resistance was estimated in apparently healthy elderly control (HC, n= 21) and neurodegenerative disease (Alzheimer's disease (AD), n= 20; Parkinson's disease (PD), n= 22) groups using Homeostasis Model Assessment of Insulin Resistance 2 (HOMA2) and intravenous glucose tolerance test (IVGTT). HOMA2 and GMV were assessed within groups through General Linear Model multiple regression. We found that HOMA2 was increased in both AD and PD compared to the HC group (HC vs. AD, p= 0.002, HC vs. PD, p= 0.003), although only AD subjects exhibited increased fasting glucose (p= 0.005). Furthermore, our voxel-based morphometry analysis revealed that HOMA2 was related to GMV in all cohorts in a region-specific manner (p<. 0.001, uncorrected). Significant relationships were observed in the medial prefrontal cortex (HC), medial temporal regions (AD), and parietal regions (PD). Finally, the directionality of the relationship between HOMA2 and GMV was disease-specific. Both HC and AD subjects exhibited negative relationships between HOMA2 and brain volume (increased HOMA2 associated with decreased brain volume), while a positive relationship was observed in PD. This cross-sectional study suggests that insulin resistance is increased in neurodegenerative disease, and that individuals with AD appear to have more severe metabolic dysfunction than individuals with PD or PD dementia.

AB - The goal of this study was to compare insulin resistance in aging and aging-related neurodegenerative diseases, and to determine the relationship between insulin resistance and gray matter volume (GMV) in each cohort using an unbiased, voxel-based approach. Insulin resistance was estimated in apparently healthy elderly control (HC, n= 21) and neurodegenerative disease (Alzheimer's disease (AD), n= 20; Parkinson's disease (PD), n= 22) groups using Homeostasis Model Assessment of Insulin Resistance 2 (HOMA2) and intravenous glucose tolerance test (IVGTT). HOMA2 and GMV were assessed within groups through General Linear Model multiple regression. We found that HOMA2 was increased in both AD and PD compared to the HC group (HC vs. AD, p= 0.002, HC vs. PD, p= 0.003), although only AD subjects exhibited increased fasting glucose (p= 0.005). Furthermore, our voxel-based morphometry analysis revealed that HOMA2 was related to GMV in all cohorts in a region-specific manner (p<. 0.001, uncorrected). Significant relationships were observed in the medial prefrontal cortex (HC), medial temporal regions (AD), and parietal regions (PD). Finally, the directionality of the relationship between HOMA2 and GMV was disease-specific. Both HC and AD subjects exhibited negative relationships between HOMA2 and brain volume (increased HOMA2 associated with decreased brain volume), while a positive relationship was observed in PD. This cross-sectional study suggests that insulin resistance is increased in neurodegenerative disease, and that individuals with AD appear to have more severe metabolic dysfunction than individuals with PD or PD dementia.

KW - Alzheimer's disease

KW - Dementia

KW - Glucose tolerance

KW - Insulin resistance

KW - Metabolism

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84899689416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899689416&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2014.04.006

DO - 10.1016/j.neuroscience.2014.04.006

M3 - Article

C2 - 24735819

AN - SCOPUS:84899689416

VL - 270

SP - 139

EP - 147

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -